Disease or condition-specific regenerative applications of nanostructured materials, such as those designed for osteogenesis, neurogenesis, or dermal regeneration, to enhance therapeutic effectiveness ...
KDEV) today announces that its portfolio company BOOST Pharma has succesfully completed a pre-IND meeting with the U.S. Food and Drug Administration, FDA, for its cell therapy aiming to treat children ...